HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

MAC: Loud Lash is an "extra-strength mascara [that] is non-flaking, non-smudging, waterproof, smear-proof and tear-proof thanks to a unique new polymer in the formula," Estee Lauder division says. Mascara will be available in Noisy Black and Boom Brown for $11 in October. Company also announces Debbie Harry, Dita Von Teese, Eve and Lisa Marie Presley as spokespeople for the MAC VIVA GLAM VI campaign. Latest campaign, which raises money for the MAC AIDS Fund, features VIVA GLAM VI Lipstick, a warm terracotta-plum with a pearl finish, and VIVA GLAM VI Lipglass, a subtle terracotta-peach with pearl, firm says. Products are available now for $14 and $13.50, respectively. VIVA GLAM VI will be supported by in-store black and white portraits that highlight the four women's "provocative personalities," firm says...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014220

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel